{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T09:17:06Z","timestamp":1781083026995,"version":"3.54.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.drugalcdep.2006.09.022","type":"journal-article","created":{"date-parts":[[2007,2,5]],"date-time":"2007-02-05T11:02:50Z","timestamp":1170673370000},"page":"S64-S72","source":"Crossref","is-referenced-by-count":57,"special_numbering":"S1","title":["Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users"],"prefix":"10.1016","volume":"91","author":[{"given":"Jennifer V.","family":"Campbell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Garfein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Thiede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Hagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry J.","family":"Ouellet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth T.","family":"Golub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon M.","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle C.","family":"Ompad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Weinbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2006.09.022_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/jurban\/jti016","article-title":"Adherence to hepatitis B virus vaccination at syringe exchange sites","volume":"82","author":"Altice","year":"2005","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib2","doi-asserted-by":"crossref","first-page":"14S","DOI":"10.1016\/0002-9343(89)90525-1","article-title":"Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine","volume":"87","author":"Andre","year":"1989","journal-title":"Am. J. Med."},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib3","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1086\/314518","article-title":"The diverse patterns of hepatitis A epidemiology in the United States\u2014implications for vaccination strategies","volume":"178","author":"Bell","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib4","series-title":"Presented at 38th National Immunization Conference","first-page":"11","article-title":"Cost-effectiveness of prevaccination testing for anti-HBc at sexually transmitted disease clinics in the United States. Abstract #5188","author":"Billah","year":"2004"},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.1360-0443.1999.9444894.x","article-title":"Methadone-maintained former heroin addicts, including those who are anti-HIV-1 seropositive, comply with and respond to hepatitis B vaccination","volume":"94","author":"Borg","year":"1999","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib6","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/archinte.1994.00420060093010","article-title":"Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines","volume":"154","author":"Bryan","year":"1994","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib7","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1016\/S0264-410X(01)00221-3","article-title":"Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine in healthy adolescent volunteers: an open, randomised study","volume":"19","author":"Burgess","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib8","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1542\/peds.107.4.626","article-title":"A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunologic memory","volume":"107","author":"Cassidy","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib9","article-title":"Recommendation of the Immunization Practices Advisory Committee (ACIP) inactivated hepatitis B virus vaccine","volume":"31","author":"CDC","year":"1982","journal-title":"MMWR"},{"issue":"RR-13","key":"10.1016\/j.drugalcdep.2006.09.022_bib10","first-page":"1","article-title":"Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee (ACIP)","volume":"40","author":"CDC","year":"1991","journal-title":"MMWR"},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib11","first-page":"574","article-title":"Notice to readers update: recommendations to prevent hepatitis B Virus Transmission\u2014United States","volume":"44","author":"CDC","year":"1995","journal-title":"MMWR"},{"issue":"RR-13","key":"10.1016\/j.drugalcdep.2006.09.022_bib12","first-page":"1","article-title":"Immunization of adolescents: recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association","volume":"45","author":"CDC","year":"1996","journal-title":"MMWR"},{"issue":"RR15","key":"10.1016\/j.drugalcdep.2006.09.022_bib13","first-page":"1","article-title":"Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"45","author":"CDC","year":"1996","journal-title":"MMWR"},{"issue":"RR12","key":"10.1016\/j.drugalcdep.2006.09.022_bib14","first-page":"1","article-title":"Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"48","author":"CDC","year":"1999","journal-title":"MMWR"},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib15","article-title":"Hepatitis B vaccination for injection drug users\u2014Pierce County, Washington, 2000","volume":"50","author":"CDC","year":"2001","journal-title":"MMWR"},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib16","first-page":"618","article-title":"Hepatitis B vaccination among high-risk adolescents and adults\u2014San Diego, California, 1998\u20132001","volume":"51","author":"CDC","year":"2002","journal-title":"MMWR"},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib17","article-title":"Achievements in public health: hepatitis B vaccination\u2014United States, 1982\u20132002","volume":"51","author":"CDC","year":"2002","journal-title":"MMWR"},{"issue":"RR06","key":"10.1016\/j.drugalcdep.2006.09.022_bib18","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines\u20142002","volume":"51","author":"CDC","year":"2002","journal-title":"MMWR"},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib19","first-page":"681","article-title":"Hepatitis B vaccination of inmates in correctional facilities\u2014Texas, 2000\u20132002","volume":"53","author":"CDC","year":"2004","journal-title":"MMWR"},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib20","unstructured":"CDC, 2005. [homepage on the Internet]. Atlanta, GA. Surveillance Summary No. 59. Available at: http:\/\/www.cdc.gov\/ncidod\/diseases\/hepatitis\/resource\/PDFs\/hep_surveillance_59.pdf. Accessed October 7, 2005."},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF02287705","article-title":"Satisfaction with access to health care among injection drug users, other drug users and nonusers","volume":"29","author":"Chitwood","year":"2002","journal-title":"J. Behav. Health Serv. Res."},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib22","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.2105\/AJPH.91.11.1791","article-title":"Providing hepatitis B vaccination to injection drug users: referral to health clinics vs. on-site vaccination at a syringe exchange program","volume":"91","author":"DesJarlais","year":"2001","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib23","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2105\/AJPH.86.5.655","article-title":"Viral infections in short-term injection drug users: the prevalence of hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses","volume":"86","author":"Garfein","year":"1996","journal-title":"AJPH"},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2006.09.022_bib24","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.drugalcdep.2007.05.007","article-title":"Methods to recruit and retain young-adult injection drug users for intervention trials: The CIDUS III\/DUIT study experience","volume":"91","author":"Garfein","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib25","first-page":"306","article-title":"Increasing hepatitis B vaccine coverage in prisons in England and Wales","volume":"7","author":"Gilbert","year":"2004","journal-title":"Commun. Dis. Public Health"},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib26","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1086\/339192","article-title":"Incidence and risk factors for acute hepatitis B in the United States 1982\u20131998: implications for vaccination programs","volume":"185","author":"Goldstein","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib27","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.315.7110.703","article-title":"Should we pay the patient? Review of financial incentives to enhance patient compliance","volume":"315","author":"Guiffrida","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/oxfordjournals.aje.a009792","article-title":"Syringe exchange and risk of infection with hepatitis B and C viruses","volume":"149","author":"Hagan","year":"1999","journal-title":"AJE"},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF02350966","article-title":"Volunteer bias in nonrandomized evaluations of the efficacy of needle-exchange programs","volume":"77","author":"Hagan","year":"2000","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib30","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.2105\/AJPH.92.11.1756","article-title":"Hepatitis B vaccination among research participants, Seattle Washington","volume":"92","author":"Hagan","year":"2002","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00042560-199706010-00010","article-title":"Who uses needle exchange? A study of injection drug users in treatment in San Francisco 1989\u20131990","volume":"15","author":"Hahn","year":"1997","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib32","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.vaccine.2004.05.019","article-title":"Sudden rise in uptake of hepatitis B vaccination among injecting drug users associated with a universal vaccine programme in prisons","volume":"23","author":"Hutchinson","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib33","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2105\/AJPH.89.6.918","article-title":"Identifying target groups for a potential vaccination program during a hepatitis A communitywide outbreak","volume":"89","author":"Hutin","year":"1999","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib34","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1086\/318131","article-title":"Prevalence of sexually transmitted infections and associated risk factors among populations of drug abusers","volume":"31","author":"Hwang","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.amepre.2004.07.002","article-title":"A structured review of the effect of economic incentives on consumers\u2019 preventive behavior","volume":"27","author":"Kane","year":"2004","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.drugalcdep.2003.10.007","article-title":"Hepatitis B virus infection and vaccination among young injection and non-injection drug users: missed opportunities to prevent infection","volume":"73","author":"Kuo","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib37","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1086\/381440","article-title":"Poor validity of self-reported hepatitis B virus infection and vaccination status among young drug users","volume":"38","author":"Kuo","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib38","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/1054-139X(95)00165-O","article-title":"Hepatitis B immunization in adolescents","volume":"17","author":"Lawrence","year":"1995","journal-title":"J. Adolesc. Health"},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib39","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/oxfordjournals.epirev.a036161","article-title":"Epidemiology of hepatitis B virus infections among injecting drug users: seroprevalence, risk factors, and viral interactions","volume":"16","author":"Levine","year":"1994","journal-title":"Epidemiol. Rev."},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib40","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/jurban\/78.4.690","article-title":"Substance abuse and high-risk needle-related behaviors among homeless youth in Minneapolis: implications for prevention","volume":"78","author":"Lifson","year":"2001","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib41","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0264-410X(96)00290-3","article-title":"Immunoresponse to hepatitis B vaccination and adherence campaign among injecting drug users","volume":"15","author":"Lugoboni","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib42","series-title":"Paper Presented at: 127th Annual Meeting of the American Public Health Association","article-title":"Low rates of hepatitis B vaccination among young injectors in San Francisco","author":"Lum","year":"1999"},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib43","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2105\/AJPH.93.6.919","article-title":"Hepatitis B virus immunization among young injection drug users in San Francisco Calif: the UFO Study","volume":"93","author":"Lum","year":"2003","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib44","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2105\/AJPH.92.3.385","article-title":"Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities","volume":"92","author":"Murrill","year":"2002","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib45","first-page":"294","article-title":"Acceptance and completion of hepatitis B vaccination among drug users in New York City","volume":"7","author":"Ompad","year":"2004","journal-title":"Commun. Dis. Public Health"},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib46","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1467-842X.2005.tb00197.x","article-title":"An accelerated hepatitis B vaccination schedule for young drug users","volume":"29","author":"Rogers","year":"2005","journal-title":"Aust. N. Z. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib47","first-page":"99","article-title":"Validity of injecting drug users\u2019 self report of hepatitis A, B, and C","volume":"16","author":"Schlicting","year":"2003","journal-title":"Clin. Lab. Sci."},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib48","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/ewjm.172.1.16","article-title":"Risk of hepatitis B infection among young injection drug users in San Francisco: opportunities for intervention","volume":"172","author":"Seal","year":"2000","journal-title":"West. J. Med."},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0376-8716(03)00074-7","article-title":"A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users","volume":"71","author":"Seal","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib50","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2105\/AJPH.90.3.447","article-title":"Vaccination strategies for targeted and difficult-to-access groups","volume":"90","author":"Trubatch","year":"2000","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib51","series-title":"Program & Abstracts Book. International Conference on Emerging Infectious Diseases","first-page":"118","article-title":"Epidemic hepatitis A among illicit drug users in Oregon: evidence for adult-to-adult transmission","author":"Van Beneden","year":"1998"},{"key":"10.1016\/j.drugalcdep.2006.09.022_bib52","first-page":"324","article-title":"Comparison of conventional and accelerated hepatitis B immunisation schedules for homeless drug users","volume":"5","author":"Wright","year":"2002","journal-title":"Commun. Dis. Public Health"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871606004613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871606004613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T07:54:56Z","timestamp":1547020496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871606004613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":52,"alternative-id":["S0376871606004613"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2006.09.022","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}